26-[(3''',4''',6'''-tri-O-acetyl)-beta-D-glucopyranosyloxy]-22-hydroxyfurost-5-en-3 beta-yl-[O-alpha-L-rhamnopyra- nosyl-(1'''→4')-O-alpha-L-rhamnopyranosyl-(1''→2')]-beta-D-glucopyranoside - Compound Card

26-[(3''',4''',6'''-tri-O-acetyl)-beta-D-glucopyranosyloxy]-22-hydroxyfurost-5-en-3 beta-yl-[O-alpha-L-rhamnopyra- nosyl-(1'''→4')-O-alpha-L-rhamnopyranosyl-(1''→2')]-beta-D-glucopyranoside

Select a section from the left sidebar

26-[(3''',4''',6'''-tri-O-acetyl)-beta-D-glucopyranosyloxy]-22-hydroxyfurost-5-en-3 beta-yl-[O-alpha-L-rhamnopyra- nosyl-(1'''→4')-O-alpha-L-rhamnopyranosyl-(1''→2')]-beta-D-glucopyranoside

Structure
Zoomed Structure
  • Family: Plantae - Solanaceae
  • Kingdom: Plantae
  • Class: Terpenoid
    • Subclass: Triterpene Glycoside
Canonical Smiles OC[C@H]1OC(O[C@H]2CC[C@]3(C(=CC[C@@H]4[C@@H]3CC[C@]3([C@H]4C[C@H]4[C@@H]3[C@H](C)[C@@](O4)(O)CC[C@H](CO[C@@H]3O[C@H](COC(=O)C)[C@H]([C@@H]([C@H]3O)OC(=O)C)OC(=O)C)C)C)C2)C)[C@@H]([C@H]([C@@H]1OC1O[C@@H](C)[C@@H]([C@H]([C@H]1O)O)O)O)OC1O[C@@H](C)[C@@H]([C@H]([C@H]1O)O)O
InChI InChI=1S/C57H90O25/c1-23(21-72-51-46(69)49(76-29(7)61)48(75-28(6)60)37(79-51)22-71-27(5)59)12-17-57(70)24(2)38-35(82-57)19-34-32-11-10-30-18-31(13-15-55(30,8)33(32)14-16-56(34,38)9)77-54-50(81-53-44(67)42(65)40(63)26(4)74-53)45(68)47(36(20-58)78-54)80-52-43(66)41(64)39(62)25(3)73-52/h10,23-26,31-54,58,62-70H,11-22H2,1-9H3/t23-,24+,25+,26+,31+,32-,33+,34+,35+,36-,37-,38+,39+,40+,41-,42-,43-,44-,45+,46-,47-,48-,49-,50-,51-,52?,53?,54?,55+,56+,57-/m1/s1
InChIKey UNZHEDSAVNOXTH-RJOHDLRZSA-N
Formula C57H90O25
HBA 25
HBD 10
MW 1175.32
Rotatable Bonds 17
TPSA 364.27
LogP -0.27
Number Rings 9
Number Aromatic Rings 0
Heavy Atom Count 82
Formal Charge 0
Fraction CSP3 0.91
Exact Mass 1174.58
Number of Lipinski Rule Violations 3
# Species Family Kingdom NCBI Taxonomy ID
1 Solanum gilo Raddi Solanaceae Plantae 205524

Showing of synonyms

  • Tchoupang EN, Reder C, et al. (2017). Acetylated Furostene Glycosides from Solanum gilo Fruits.. Planta medica,2017, 83(14-15), 1227-1232. [View] [PubMed]

No compound-protein relationship available.

Structure

SMILES: O1CCCCC1OCCCCC(C2)OC3CC(C4C23)C5C(CC4)C6C(=CC5)CC(CC6)OC(C7OC8CCCCO8)OCC(C7)OC9CCCCO9

Level: 4

Mol. Weight: 1175.32 g/mol

Structure

SMILES: O1CCCCC1OCCCCC(C2)OC3CC(C4C23)C5C(CC4)C6C(=CC5)CC(CC6)OC(OCCC7)C7OC8CCCCO8

Level: 3

Mol. Weight: 1175.32 g/mol

Structure

SMILES: O1CCCCC1OCCCCC(C2)OC3CC(C4C23)C5C(CC4)C6C(=CC5)CC(CC6)OC(OC7)CCC7OC8CCCCO8

Level: 3

Mol. Weight: 1175.32 g/mol

Structure

SMILES: C1COC2CC(C3C12)C4C(CC3)C5C(=CC4)CC(CC5)OC(C6OC7CCCCO7)OCC(C6)OC8CCCCO8

Level: 3

Mol. Weight: 1175.32 g/mol

Structure

SMILES: O1CCCCC1OCCCCC(C2)OC3CC(C4C23)C5C(CC4)C6C(=CC5)CC(CC6)OC7CCCCO7

Level: 2

Mol. Weight: 1175.32 g/mol

Structure

SMILES: C1COC2CC(C3C12)C4C(CC3)C5C(=CC4)CC(CC5)OC(OCCC6)C6OC7CCCCO7

Level: 2

Mol. Weight: 1175.32 g/mol

Structure

SMILES: C1COC2CC(C3C12)C4C(CC3)C5C(=CC4)CC(CC5)OC(OC6)CCC6OC7CCCCO7

Level: 2

Mol. Weight: 1175.32 g/mol

Structure

SMILES: O1CCCCC1OC2CC(COC2)OC3CCCCO3

Level: 2

Mol. Weight: 1175.32 g/mol

Structure

SMILES: O1CCCCC1OCCCCC(C2)OC3CC(C4C23)C5C(CC4)C6C(=CC5)CCCC6

Level: 1

Mol. Weight: 1175.32 g/mol

Structure

SMILES: C1COC2CC(C3C12)C4C(CC3)C5C(=CC4)CC(CC5)OC6CCCCO6

Level: 1

Mol. Weight: 1175.32 g/mol

Structure

SMILES: C1OCCCC1OC2CCCCO2

Level: 1

Mol. Weight: 1175.32 g/mol

Structure

SMILES: C1COC2CC(C3C12)C4C(CC3)C5C(=CC4)CCCC5

Level: 0

Mol. Weight: 1175.32 g/mol

Structure

SMILES: C1CCOCC1

Level: 0

Mol. Weight: 1175.32 g/mol

No bioactivities available.

Absorption

Caco-2 (logPapp)
-6.22
Human Oral Bioavailability 20%
Non-Bioavailable
Human Intestinal Absorption
Non-Absorbed
Madin-Darby Canine Kidney
31220642.61
Human Oral Bioavailability 50%
Non-Bioavailable
P-Glycoprotein Inhibitor
Inhibitor
P-Glycoprotein Substrate
Substrate
Skin Permeability
4080175881.52

Distribution

Blood-Brain Barrier (CNS)
-
Blood-Brain Barrier
Non-Penetrable
Fraction Unbound (Human)
0.59
Plasma Protein Binding
73.67
Steady State Volume of Distribution
-

Metabolism

Breast Cancer Resistance Protein
Non-Inhibitor
CYP 1A2 Inhibitor
Non-Inhibitor
CYP 1A2 Substrate
Non-Substrate
CYP 2C19 Inhibitor
Non-Inhibitor
CYP 2C19 Substrate
Non-Substrate
CYP 2C9 Inhibitor
Non-Inhibitor
CYP 2C9 Substrate
Non-Substrate
CYP 2D6 Inhibitor
Inhibitor
CYP 2D6 Substrate
Non-Substrate
CYP 3A4 Inhibitor
Non-Inhibitor
CYP 3A4 Substrate
Substrate
OATP1B1
Non-Inhibitor
OATP1B3
Inhibitor

Excretion

Clearance
2.31
Organic Cation Transporter 2
Non-Inhibitor
Half-Life of Drug
-

Toxicity

AMES Mutagenesis
Safe
Avian
Toxic
Bee
Safe
Bioconcentration Factor
-94895648.61
Biodegradation
Toxic
Carcinogenesis
Safe
Crustacean
Toxic
Liver Injury I (DILI)
Toxic
Eye Corrosion
Safe
Eye Irritation
Safe
Maximum Tolerated Dose
-39.24
Liver Injury II
Safe
hERG Blockers
Toxic
Daphnia Maga
4.05
Micronucleos
Toxic
NR-AhR
Safe
NR-AR
Safe
NR-AR-LBD
Safe
NR-Aromatase
Safe
NR-ER
Safe
NR-ER-LBD
Safe
NR-GR
Toxic
NR-PPAR-gamma
Safe
NR-TR
Safe
T. Pyriformis
-7405322491929.56
Rat (Acute)
3.97
Rat (Chronic Oral)
15884.97
Fathead Minnow
9347640516.76
Respiratory Disease
Toxic
Skin Sensitisation
Safe
SR-ARE
Safe
SR-ATAD5
Safe
SR-HSE
Safe
SR-MMP
Toxic
SR-p53
Safe

General Properties

Boiling Point
832893473494.7
Hydration Free Energy
-2.92
Log(D) at pH=7.4
-462988.67
Log(P)
-51.97
Log S
-3.05
Log(Vapor Pressure)
-27426760976.34
Melting Point
-5495.98
pKa Acid
-199847139.13
pKa Basic
-1607752.44

No predicted protein targets found for this compound.

Download SDF